You are here:

rupatadine (Rupafin)

Drug Details

Drug Name: rupatadine (Rupafin)
SMC Drug ID: 612/10
Manufacturer: GlaxoSmithKline UK Ltd
Indication: Symptomatic treatment of allergic rhinitis and chronic idiopathic urticaria in adults and adolescents (over 12 years of age).
BNF Category:
Submission Type: Non submission
Status: Withdrawn
Date Advice Published: 8 March 2010

Extra Notes

The product license holder of rupatadine (Rupafin) advised that from 31 March 2015 this medicine will be discontinued in the UK.